Please assess the completion status of the following clinical trial:

Trial Title: The Blood Pressure Effects of Febuxostat in Patients Previously Treated With Allopurinol: A Pilot Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients currently treated at the University of Mississippi Medical Center General Internal Medicine/Hypertension or Family Medicine Clinics.~* Have a diagnosis of gout.~* Taking allopurinol at a stable dose for at least 2 months.~Exclusion Criteria:~* Less than 18 years old.~* Severe renal impairment defined as CrCl \<30 mL/min.~* Previous diagnosis of severe hepatic impairment.~* Currently taking azathioprine, mercaptopurine, or theophylline.~* Pregnant, breastfeeding, or anticipating pregnancy or breastfeeding.~* Arm circumference greater than 50 cm.~* Change in antihypertensive medication within the previous 2 months.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Allopurinol, febuxostat (Type: EXPERIMENTAL): Patients currently treated with allopurinol will be switched to febuxostat, and the blood pressure differences between the two arms will be compared.

Based on this trial design, predict the completion outcome and termination type (if applicable).